“Meet the Newest Addition to Our Board: Dipal Doshi Brings Fresh Perspective and Plenty of Dad Jokes to Azenta!”
Welcome to the Board, Dipal Doshi! A New Addition to the Azenta, Inc. Family BURLINGTON, Mass. , Jan. 30, 2025 /PRNewswire/ — Azenta, Inc. (Nasdaq: AZTA) made a big announcement today at its Annual Meeting of Stockholders – the addition of Dipal Doshi, Chief Executive Officer of Entrada Therapeutics (NASDAQ: TRDA), to its Board of…